IEH Corporation filings document material events for a New York manufacturer of PCB connectors, custom interconnects, contacts, and Hyperboloid connector technology. Its recent Form 8-K reports cover financial-results releases, order and backlog announcements tied to defense programs, Regulation FD presentation materials, and the quotation status of IEHC common stock on OTC markets.
The company’s filings also record shareholder voting matters from its annual meeting, securities-registration status, governance disclosures, and the dismissal of an SEC administrative proceeding related to past late filings. These documents frame IEH’s public reporting around operating performance, market access, corporate governance, and regulatory status.
IEH Corp (IEHC) Chief Financial Officer Subrata Purkayastha exercised non-qualified stock options covering 35,000 common shares on October 23, 2026, at an exercise price of $29.60 per share. His reported direct post-transaction position was 70,000 non-qualified stock options.
IEH Corp (IEHC) entered an employment agreement with Subrata Purkayastha, its Chief Financial Officer, Treasurer and Corporate Secretary, on October 23, 2026. The agreement is effective November 1, 2026, through October 31, 2029, with annual base salary of $293,950 and eligibility for a bonus of up to 100% of base salary based on objectives set by the Compensation Committee.
She will receive 35,000 immediately vested options to purchase common stock at $29.60 per share, for the fiscal year ended March 31, 2027. Termination without cause by IEH or resignation for good reason entitles her to 24 months of base salary, up to 24 months of health and welfare plan participation, and accrued unpaid compensation. Within the three-year period of a change in control, IEH must provide substantially the same compensation and benefits if her employment is terminated or her title, position or responsibilities are materially reduced and she terminates employment; a limitation applies to payments that would constitute an excess parachute payment subject to an excise tax.
IEH Corporation is seeking shareholder votes at its November 12, 2026 hybrid annual meeting on four Class I director seats, advisory approval of named executive compensation, the frequency of future say-on-pay votes, and ratification of CBIZ CPAs P.C. for the fiscal year ending March 31, 2027. The board recommends annual say-on-pay votes and recommends “FOR” each proposal. Shareholders of record on October 5, 2026, were eligible to vote; 2,487,454 common shares were issued and outstanding on that date, with one vote per share.
IEH reported a material weakness in internal control over financial reporting as of March 31, 2026, tied to ineffective IT general controls for change management and user access, together with a lack of properly designed management-review controls. The CEO and CFO concluded that internal control over financial reporting and disclosure controls and procedures were not effective. Management’s remediation plan includes enhanced monitoring and changes to user access and change management. Fiscal 2026 compensation totaled $566,319 for CEO and President Dave Offerman and $292,493 for CFO Subrata Purkayastha. Auditor fees included $266,750 for audit services and $17,000 for tax services in fiscal 2026.
IEH Corporation (IEHC) received $3.6 million in new orders for its Hyperboloid connectors from a leading manufacturer of mobile defibrillators. The company says the medical market is a strategic growth priority and the orders complement its record defense backlog, alongside recent defense orders supporting the PATRIOT and APKWS missile programs.
The connectors use angled wires around a mating pin to create multiple contact lines. IEH says the design resists shock and vibration and supports an exceptionally high number of mating cycles with low insertion force.
IEH Corp (IEHC) reported an amended insider trading disclosure for director Michael E. Rosenfeld. The amendment corrects dates and prices from a prior Form 4 filed on August 20, 2026 and adds further sales of common stock. On September 3–4, 2026, Rosenfeld reported selling a total of 5,000 shares of IEH common stock in open market or private transactions at prices between $32.51 and $32.95 per share. No Rule 10b5-1 trading plan is indicated, and the filing does not state Rosenfeld’s holdings after these transactions.
IEH Corp (IEHC) received a Rule 144 notice that director Michael E. Rosenfeld intends to sell 5,000 shares of the company’s common stock. The shares are planned to be sold through Fidelity Brokerage Services LLC on the OTCQX market with an aggregate market value of $162,500.
The shares were acquired from IEH Corp by option exercise on February 2, 2026. Shares of IEH Corp outstanding were 2,478,692 as of September 3, 2026; this is a baseline figure, not the amount being sold.
IEH Corp (IEHC) director Michael E. Rosenfeld reported open-market sales of the company’s common stock. On August 13, 2026, he sold 3,000 shares at $33.00 per share, and on August 14, 2026, he sold 1,240 shares at $32.50 per share, for total reported sales of 4,240 shares.
IEH Corp insider Gail Offerman, a more-than-10% owner, reported a sale of common stock. On 2026-08-13, Offerman sold 2,000 shares of IEH Corp common stock at $32.25 per share in an open market or private transaction. After this sale, Offerman directly holds 497,606 shares of IEH Corp common stock.
IEH Corporation filed its quarterly report on Form 10-Q for the first quarter of Fiscal Year 2027, covering the quarter ended June 30, 2026. Revenue was $10,021,446, up from $6,308,155 a year earlier, a 59% increase. The company reported operating profit of $664,802 versus an operating loss of $755,306, and net income of $654,466 versus a net loss of $654,618. Basic earnings per share were $0.26, compared with a basic loss per share of $0.27 in the prior-year quarter.
Management noted that revenue reached an all-time high of just over $10 million, gross margins nearly doubled, backlog remains at an all-time high, and IEH is hiring and adding capacity to meet strong demand in defense, commercial aerospace, space and medical markets. Forward-looking statements highlight risks including factors related to past due periodic reports and SEC proceedings under Section 12(j), efforts to remediate an inventory accounting issue, macroeconomic conditions, cost control and revenue growth, accounting changes, and the ability to attract and retain key employees.